NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) - ANVISA Registration 10345162305

Access comprehensive regulatory information for NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10345162305 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Oct 15, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.